SCHEMBL10029026

SCHEMBL10029026

C[C@@H](C(=O)Oc1ccccc1)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.61
ATM Q13315 1/20 0.61
ELANE P08246 2/20 0.51
LMNA P02545 2/20 0.51
PTGS1 P23219 2/20 0.50
PTGS2 P35354 3/20 0.49
KMT2A Q03164 3/20 0.47
NPY5R Q15761 1/20 0.45
MEN1 O00255 2/20 0.45
CYP2D6 P10635 1/20 0.45
ALDH1A1 P00352 1/20 0.42
TP53 P04637 1/20 0.42
GAA P10253 1/20 0.42
MGLL Q99685 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1046956 1.00 L3MBTL1 (0.61) L3MBTL1ATMELANELMNAPTGS1
Iodide SCHEMBL28946796 0.98 L3MBTL1 (0.59) L3MBTL1ATMELANELMNAPTGS1
SCHEMBL28720971 0.89 PTGS2 (0.58) L3MBTL1ATMELANEPTGS2KMT2A
SCHEMBL28968070 0.89 ALDH1A1 (0.52) L3MBTL1ATMELANELMNAPTGS2
SCHEMBL28926942 0.89 GPR88 (0.54) L3MBTL1ATMELANEPTGS2KMT2A
SCHEMBL27618789 0.89 L3MBTL1 (0.50) L3MBTL1ATMELANELMNAPTGS2
SCHEMBL28968068 0.88 L3MBTL1 (0.49) L3MBTL1ATMELANELMNAPTGS1
SCHEMBL28121832 0.88 GPR88 (0.52) L3MBTL1ATMELANEPTGS1PTGS2
SCHEMBL28482269 0.88 L3MBTL1 (0.49) L3MBTL1ATMELANELMNAPTGS2
Hydrochloric Acid SCHEMBL11426922 0.86 L3MBTL1 (0.47) L3MBTL1ATMELANELMNAPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2251316-B1 METHOD FOR PRODUCING OPTICALLY ACTIVE ESTER AND METHOD FOR PRODUCING OPTICALLY ACTIVE CARBOXYLIC ACID TOKYO UNIV OF SCIENCE EDUCATIONAL FOUNDATION ADMINISTRATIVE ORGANIZATION (JP) 2018-02-21 EP disclosed
CN-106431919-A Synthesis method of photoactive 2-aryl propionic acid and derivatives thereof 南京大学 2017-02-22 CN disclosed
US-8115008-B2 Method for producing optically active ester and method for producing optically active carboxylic acid TOKYO UNIVERSITY OF SCIENCE EDUCATION FOUNDATION ADMINISTRATIVE ORGANIZATION (JP) 2012-02-14 US disclosed
US-8115008-B2 Method for producing optically active ester and method for producing optically active carboxylic acid TOKYO UNIVERSITY OF SCIENCE EDUCATION FOUNDATION ADMINISTRATIVE ORGANIZATION (JP) 2012-02-14 US disclosed
US-20100234610-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE ESTER AND METHOD FOR PRODUCING OPTICALLY ACTIVE CARBOXYLIC ACID TOKYO UNIVERSITY OF SCIENCE EDUCATIONAL FOUNDATION ADMINISTRATIVE ORGANIZATION (JP) 2010-09-16 US disclosed
US-20100234610-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE ESTER AND METHOD FOR PRODUCING OPTICALLY ACTIVE CARBOXYLIC ACID TOKYO UNIVERSITY OF SCIENCE EDUCATIONAL FOUNDATION ADMINISTRATIVE ORGANIZATION (JP) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234610-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE ESTER AND METHOD FOR PRODUCING OPTICALLY ACTIVE CARBOXYLIC ACID ACADM, ADH5, ALDH7A1 L3MBTL1 3869/4885ATM 4681/4885ELANE 1154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.